These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 9326421)

  • 1. Combination leflunomide and cyclosporine prevents rejection of functional whole limb allografts in the rat.
    Yeh LS; Gregory CR; Griffey SM; Lecouter RA; Hou SM; Morris RE
    Transplantation; 1997 Sep; 64(6):919-22. PubMed ID: 9326421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of leflunomide and cyclosporine on myocutaneous allograft survival in the rat.
    Yeh LS; Gregory CR; Griffey SM; Lecouteur RA; Morris RE
    Transplantation; 1996 Sep; 62(6):861-3. PubMed ID: 8824490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leflunomide prolongs pulmonary allograft and xenograft survival.
    Yuh DD; Gandy KL; Morris RE; Hoyt G; Gutierrez J; Reitz BA; Robbins RC
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1136-44. PubMed ID: 8719461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leflunomide in experimental transplantation. Control of rejection and alloantibody production, reversal of acute rejection, and interaction with cyclosporine.
    Williams JW; Xiao F; Foster P; Clardy C; McChesney L; Sankary H; Chong AS
    Transplantation; 1994 Apr; 57(8):1223-31. PubMed ID: 8178350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of combined immunosuppression with systemic low-dose cyclosporin and topical fluocinolone acetonide on the survival of rat hind-limb allografts.
    Inceoglu S; Siemionow M; Chick L; Craven CM; Lister GD
    Ann Plast Surg; 1994 Jul; 33(1):57-65. PubMed ID: 7944198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trafficking of donor-derived bone marrow correlates with chimerism and extension of composite allograft survival across MHC barrier.
    Ozmen S; Ulusal BG; Ulusal AE; Izycki D; Yoder B; Siemionow M
    Transplant Proc; 2006 Jun; 38(5):1625-33. PubMed ID: 16797371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donor-specific tolerance in fully major histocompatibility major histocompatibility complex-mismatched limb allograft transplants under an anti-alphabeta T-cell receptor monoclonal antibody and cyclosporine A protocol.
    Siemionow MZ; Izycki DM; Zielinski M
    Transplantation; 2003 Dec; 76(12):1662-8. PubMed ID: 14688512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral leflunomide prevents small bowel allograft rejection in the rat.
    He G; McAlister VC; Lee TD; Bitter-Suermann H; Theal M; Wright J; MacDonald AS
    Transplant Proc; 1994 Jun; 26(3):1613. PubMed ID: 8030057
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunosuppressive effect of RS-61443 on rat cardiac allograft survival in combination with leflunomide or FK 506.
    D'Silva M; Antoniou E; DeRoover A; Nishimura Y; Howie A; McMaster P
    Transplant Proc; 1996 Apr; 28(2):930-1. PubMed ID: 8623467
    [No Abstract]   [Full Text] [Related]  

  • 10. Leflunomide therapy following penetrating keratoplasty in the rat.
    Coupland SE; Klebe S; Karow AC; Krause L; Kruse H; Bartlett RR; Hoffmann F
    Graefes Arch Clin Exp Ophthalmol; 1994 Oct; 232(10):622-7. PubMed ID: 8001831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leflunomide controls rejection in hamster to rat cardiac xenografts.
    Xiao F; Chong AS; Foster P; Sankary H; McChesney L; Koukoulis G; Yang J; Frieders D; Williams JW
    Transplantation; 1994 Oct; 58(7):828-34. PubMed ID: 7940718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extension of composite tissue allograft survival across major histocompatibility barrier under short course of anti-lymphocyte serum and cyclosporine a therapy.
    Ozer K; Gurunluoglu R; Zielinski M; Izycki D; Unsal M; Siemionow M
    J Reconstr Microsurg; 2003 May; 19(4):249-56. PubMed ID: 12858248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histological characterization and pharmacological control of chronic rejection in xenogeneic and allogeneic heart transplantation.
    Shen J; Chong AS; Xiao F; Liu W; Huang W; Blinder L; Foster P; Sankary H; Jensik S; McChesney L; Mital D; Williams JW
    Transplantation; 1998 Sep; 66(6):692-8. PubMed ID: 9771831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of rapamycin and FK 506 in prolonging rat hind limb allograft survival.
    Fealy MJ; Umansky WS; Bickel KD; Nino JJ; Morris RE; Press BH
    Ann Surg; 1994 Jan; 219(1):88-93. PubMed ID: 7507657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressive effect of combination schedules of brequinar with leflunomide or tacrolimus on rat cardiac allotransplantation.
    Antoniou EA; Deroover A; Howie AJ; Chondros K; McMaster P; D'Silva M
    Microsurgery; 1999; 19(2):98-102. PubMed ID: 10188834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promotion of corneal allograft survival with leflunomide.
    Niederkorn JY; Lang LS; Ross J; Mellon J; Robertson SM
    Invest Ophthalmol Vis Sci; 1994 Sep; 35(10):3783-5. PubMed ID: 8088966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of thymus in operational tolerance induction in limb allograft transplant model.
    Siemionow M; Izycki D; Ozer K; Ozmen S; Klimczak A
    Transplantation; 2006 Jun; 81(11):1568-76. PubMed ID: 16770246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of donor-specific tolerance in rat hind-limb allografts under antilymphocyte serum and cyclosporine A protocol.
    Siemionow M; Oke R; Ozer K; Izycki D; Prajapati R
    J Hand Surg Am; 2002 Nov; 27(6):1095-103. PubMed ID: 12457363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of leflunomide analogue FK778 on development of chronic rat renal allograft rejection and transforming growth factor-BETA expression.
    Rintala JM; Savikko J; Rintala SE; von Willebrand E
    Transplant Proc; 2006 Dec; 38(10):3239-40. PubMed ID: 17175234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined immunosuppression with leflunomide and cyclosporine prevents MLR-mismatched renal allograft rejection in a mongrel canine model.
    Lirtzman RA; Gregory CR; Levitski RE; Griffey SM; Yeh LS; Patz JD; Morris RE
    Transplant Proc; 1996 Apr; 28(2):945-7. PubMed ID: 8623474
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.